| 1230 |
TRPV1 activation, TRPV1
Short Name
TRPV1 activation, TRPV1
|
1 |
Molecular |
Nov 29, 2016 |
Dec 3, 2016 |
None
|
| 1231 |
Oxidization of biomolecules, Lipid bilayer and cellular proteins
Short Name
Oxidization of biomolecules, Lipid bilayer and cellular proteins
|
0 |
|
Nov 29, 2016 |
Nov 29, 2016 |
None
|
| 1232 |
Production of nerve growth factor ,
Short Name
Production of nerve growth factor ,
|
0 |
|
Nov 29, 2016 |
Nov 29, 2016 |
None
|
| 1233 |
Production, Nerve growth factor
Short Name
Production, Nerve growth factor
|
0 |
|
Nov 29, 2016 |
Nov 29, 2016 |
None
|
| 1234 |
Production of nerve growth factor , Epithelial irritation
Short Name
Production of nerve growth factor , Epithelial irritation
|
2 |
Tissue |
Nov 29, 2016 |
Dec 3, 2016 |
None
|
| 1235 |
Non-neuronal production of IL-8/CXCL1, Epithelial irritation
Short Name
Non-neuronal production of IL-8/CXCL1, Epithelial irritation
|
3 |
Tissue |
Nov 29, 2016 |
Dec 3, 2016 |
None
|
| 1236 |
Generation of novel epitopes , Antigen presentation
Short Name
Generation of novel epitopes , Antigen presentation
|
1 |
Cellular |
Nov 29, 2016 |
Dec 3, 2016 |
None
|
| 1237 |
Sensitization, Immune system
Short Name
Sensitization, Immune system
|
1 |
Individual |
Nov 29, 2016 |
Dec 3, 2016 |
None
|
| 1238 |
Activation of oxidative stress pathway
Short Name
Oxidation
|
3 |
Molecular |
Nov 29, 2016 |
Jun 19, 2017 |
None
|
| 1239 |
Altered, Gene Expression
Short Name
Altered, Gene Expression
|
1 |
Molecular |
Nov 29, 2016 |
Mar 6, 2019 |
2 AOPs
|
| 1240 |
Altered, Protein Production
Short Name
Altered, Protein Production
|
1 |
Cellular |
Nov 29, 2016 |
Sep 16, 2017 |
200: Estrogen receptor activation leading to breast cancer
|
| 1241 |
Increased, Motility
Short Name
Increased, Motility
|
1 |
Cellular |
Nov 29, 2016 |
Feb 28, 2024 |
2 AOPs
|
| 1242 |
Increased, Second Messenger Production
Short Name
Increased, Second Messenger Production
|
1 |
Cellular |
Nov 29, 2016 |
Sep 16, 2017 |
200: Estrogen receptor activation leading to breast cancer
|
| 1243 |
Altered, Ca2+-calmodulin activated signal transduction
Short Name
Altered, Ca2+-calmodulin activated signal transduction
|
3 |
Cellular |
Nov 29, 2016 |
Jun 7, 2018 |
4 AOPs
|
| 1244 |
Mucus hypersecretion,
Short Name
Mucus hypersecretion,
|
0 |
|
Nov 29, 2016 |
Nov 29, 2016 |
None
|
| 1245 |
Mucus , Hypersecretion
Short Name
Mucus , Hypersecretion
|
0 |
|
Nov 29, 2016 |
Nov 29, 2016 |
None
|
| 1246 |
Lung function, Decrease
Short Name
Lung function, Decrease
|
0 |
|
Nov 29, 2016 |
Nov 29, 2016 |
None
|
| 1247 |
EGFR , PPAR-alpha activation
Short Name
EGFR , PPAR-alpha activation
|
0 |
|
Nov 29, 2016 |
Nov 29, 2016 |
None
|
| 1248 |
EGFR , Activation
Short Name
EGFR , Activation
|
0 |
|
Nov 29, 2016 |
Nov 29, 2016 |
None
|
| 1250 |
Decrease, Lung function
Short Name
Decreased lung function
|
1 |
Individual |
Nov 29, 2016 |
Sep 8, 2021 |
7 AOPs
|
| 1251 |
Chronic, Mucus hypersecretion
Short Name
Chronic, Mucus hypersecretion
|
1 |
Tissue |
Nov 29, 2016 |
Aug 25, 2021 |
None
|
| 1252 |
Binding to (interferes with) topoisomerase II enzyme
Short Name
Binding, topoisomerase II
|
1 |
Molecular |
Dec 16, 2016 |
Aug 1, 2022 |
202: Inhibitor binding to topoisomerase II leading to infant leukaemia
|
| 1253 |
MLL chromosomal translocation
Short Name
MLL translocation
|
1 |
Cellular |
Dec 16, 2016 |
Aug 1, 2022 |
202: Inhibitor binding to topoisomerase II leading to infant leukaemia
|
| 1254 |
Infant leukaemia
Short Name
IFL
|
0 |
Individual |
Dec 16, 2016 |
Aug 1, 2022 |
202: Inhibitor binding to topoisomerase II leading to infant leukaemia
|
| 1255 |
induced spawning
Short Name
induced spawning
|
1 |
Individual |
Jan 13, 2017 |
Jan 13, 2017 |
195: 5-hydroxytryptamine transporter (5-HTT) inhibition leading to population increase
|